Drug Trial Radar · NCT07603401
Expanded Access Program of Bitopertin For Participants With EPP or XLP
Last checked: Nov 19, 2026Latest source record: Nov 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Available
Enrollment
Not stated
Start
Not stated
Primary completion
Not stated
Sponsor
- Lead sponsor
- Disc Medicine, IncIndustry
- Sponsor type
- Industry
- First posted
- May 22, 2026
Design
- Study type
- Expanded access
- Who can join
- All sexes, from 12 years
Summary
As written by the sponsor on the registry.
The goal of this expanded access program is to provide bitopertin to patients with EPP and XLP who have no satisfactory treatment options available in the US and to learn if bitopertin is safe to treat EPP and XLP.
Conditions
- Erythropoietic Protoporphyria (EPP)
- X-Linked Protoporphyria (XLP)
Interventions
DISC-1459Drug
DISC-1459, 60 mg oral dose once a day
Primary outcomes
What the sponsor says the trial is designed to measure.
No primary outcomes listed.
Locations
9 sites in 1 country. Site status is shown where the registry gives one.
University of Miami Miller School of Medicine
Miami, Florida · Available
Massachusetts General Hospital
Boston, Massachusetts · Available
MetroBoston Clinical Partners
Boston, Massachusetts · Available
Henry Ford Health
Detroit, Michigan · Available
Mount Sinai Hospital
New York, New York · Available
Wake Forest University
Winston-Salem, North Carolina · Available
The Cleveland Clinic Foundation
Cleveland, Ohio · Available
The University of Texas Health Science Center at Houston
Houston, Texas · Available
University of Washington
Seattle, Washington · Available
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.